This discrepancy might be attributable to differences in species-specific metabolism, translation of preclinical therapeutic dosages equivalent clinical doses, and the inability of observational human studies to control for all confounders
AOD9604 is another fragment (177-191) of the human growth hormone that binds to GH receptors and produces a GH-like effect on the metabolism of cartilage without stimulating the proliferation of cells
For example, 2-propyl-2-pentenoic acid (2-en-VPA), a byproduct of -oxidation, and 2-propyl-4-pentenoic acid (4-en-VPA), a byproduct of -oxidation, have been incriminated in the development of cerebral oedema and in the hepatotoxicity of VPA, respectively [1724]
Eli Lilly, the maker of weight-loss drug Zepbound and diabetes medication Mounjaro, is developing a muscle-retention drug called bimagrumab
It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
Sure, with that kind of commercial power and social media influence, I see the appeal of the bandwagon and why the beauty powers that be would jump on it